EDITION:
- EU
- NA
Voyager Life Voyager Life, which recently rebranded as Mendell Helium, has announced the sale of its cannabis-facing business after
Hellenic Dynamics Hellenic Dynamics has announced a further delay in the receipt of a long-term €1m loan, which has already
Ananda Developments Ananda Developments’ CEO has seemingly forced the hand of one of the UK’s most popular investment service
DanCann Pharma Danish cannabis company DanCann Pharma has announced plans to enact a reverse stock split aimed at ‘stabilising
Synbiotic New research conducted by analysts at NuWays has given German buy-and-build cannabis brand Synbiotic an updated ‘buy’ recommendation.
Ananda Developments The Aquis Stock Exchange-listed CBD life sciences company announced this week that it has successfully raised £2.1m
As Vice President Kamala Harris’s poll lead begins to dwindle, former President Donald Trump has taken to espousing uncharacteristically liberal
Argent BioPharma Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June
Jazz Pharmaceuticals The pharmaceutical giant announced last week that its flagship cannabinoid treatment, Epidyolex, failed to pass its Phase
News that the US Drug Enforcement Administration (DEA) is set to host a public administrative hearing on cannabis rescheduling has
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
